Abstract
THE variable regions of antibodies contain unique antigenic markers called idiotypes1,2. According to Jerne's network theory, antibodies reacting specifically with idiotypic determinants (anti-idiotypes) might be involved in a normal event that modulates the degree and duration of the immune response3. In view of this hypothesis anti-idiotypic antibodies may have a practical application in medicine, for example, in the treatment of autoimmune diseases or other immunological disorders. It has been suggested that the fluctuating clinical symptoms in autoimmune diseases such as myasthenia gravis or systemic lupus erythematosus are due to a regulatory effect of anti-idiotypic antibodies and that remissions are associated with an increase of specific anti-idiotypic activity4. Antibodies and antigen-binding receptors on the surface of lymphocytes share idiotypic determinants5,6. Thus, autoimmunisation with an individual's antibodies or lymphocytes carrying specific receptors for a given antigen may be an efficient way to produce specific anti-idiotypic antibodies7–9. The acetylcholine receptor (AChR) is a major autoantigen in myasthenia gravis and immunisation of animals with AChR (isolated from electric fish) results in the induction of an experimental autoimmune disease (experimental autoimmune myasthenia gravis) similar to myasthenia gravis10,11. We have therefore prepared anti-idiotypic serum specific to AChR idiotypes to test whether it can affect the immune response against AChR and the clinical state resulting from AChR sensitisation. We describe here the preparation of specific C57BL/6J antiserum against AChR-educated lymphocytes and report its anti-idiotypic activity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Oudin, J. Proc. R. Soc. B166, 207–219 (1966).
Nisonoff, H., Hopper, J. E. & Spring, S. B. The Antibody Molecule 444–496 (Academic, New York, 1975).
Jerne, N. K. Sci. Am. 229, 52–60 (1973).
Carnegie, P. R. & MacKay, I. R. Lancet ii, 684–586 (1975).
Eichmann, K. & Rajewsky, K. Eur. J. Immun. 5, 661–666 (1975).
Black, S. J., Hammerling, G. J., Berek, C., Rajewsky, K. & Eichmann, K. J. exp. Med. 143, 846–860 (1976).
Andersson, L. C., Binz, H. & Wigzell, H. Nature 264, 778–780 (1976).
Cosenza, H. Eur. J. Immun. 6, 114–119 (1975).
Cosenza, H. & Kohler, H. Proc. natn. Acad. Sci. U.S.A. 69, 2701–2705 (1972).
Patrick, J. & Lindstrom, J. M. Science 180, 871–872 (1973).
Fuchs, S., Tarrab-Hazdai, R., Nevo, D. & Bartfeld, D. in The Biochemistry of Myasthenia Gravis and Muscular Dystrophy (ed. Marchbanks, R. & Lunt, G.) (Academic, London, in the press).
Ishizaka, K. & Adachi, T. J. Immun. 117, 40–47 (1976).
Aharonov, A., Tarrab-Hazdai, R., Silman, I. & Fuchs, S. Immuno-chemistry 14, 129–137 (1977).
McDevitt, H. O. & Tyan, M. L. J. exp. Med. 128, 1–11 (1968).
Klinman, N. R. et al. Ann. Immun., Inst. Pasteur 127 C, 489–502 (1976).
Brient, B. W., Haimovich, J. & Nisonoff, A. Proc. natn. Acad. Sci. U.S.A. 68, 3136–3139 (1971).
Fuchs, S., Nevo, D., Tarrab-Hazdai, R. & Yaar, I. Nature 263, 329–330 1976).
Makela, O. & Karjalainen, K. Transplant. Rev. 34, 119–138 (1977).
Riesen, W. F., Braun, D. G. & Jaton, J.-C. Proc. natn. Acad. Sci. U.S.A. 73, 2095–2100 (1976).
Eichmann, K. J. exp. Med. 137, 603–621 (1973).
Imanishi, T. & Makela, O. J. exp. Med. 140, 1498–1510 (1974).
Makela, O., Julin, M. & Becker, M. J. exp. Med. 143, 316–328 (1976).
Fatham, C. G., Pisetsky, D. S. & Sachs, D. H. J. exp. Med. 145, 569–577 (1977).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
SCHWARTZ, M., NOVICK, D., GIVOL, D. et al. Induction of anti-idiotypic antibodies by immunisation with syngeneic spleen cells educated with acetylcholine receptor. Nature 273, 543–545 (1978). https://doi.org/10.1038/273543a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/273543a0
This article is cited by
-
Naturally occurring anti-idiotypic antibodies in myasthenia gravis patients
Nature (1983)
-
Systemic humoral factors participating in the course of spinal cord injury
Spinal Cord (1983)
-
Idiotypes and autoimmunity
Springer Seminars in Immunopathology (1983)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.